The Cancer Prevention and Research Institute of Texas (CPRIT) Oversight Committee meeting on May 21, 2025, highlighted a significant milestone for cancer research in the Rio Grande Valley. The University of Texas Rio Grande Valley (UTRGV) announced the successful acquisition of an $18.4 million grant aimed at bolstering its cancer research initiatives, a crucial development for a region that previously lacked dedicated cancer research facilities.

Dr. Hernandez, representing UTRGV, emphasized the importance of this funding, noting that the institution serves approximately 1.4 million people in South Texas. Since the establishment of their cancer research program in 2019, UTRGV has made strides in grant submissions, with a reported $90 million in applications submitted in the last cycle. While acknowledging the competitive landscape dominated by top-tier institutions like MD Anderson, Dr. Hernandez expressed optimism about UTRGV's growing presence in the field.

The grant will support various cancer programs, including partnerships with organizations such as the Good Days Foundation and the Costin Foundation, which focus on breast and pancreatic cancer, respectively. Dr. Hernandez underscored the collaborative efforts with local foundations and industries, indicating a proactive approach to enhancing cancer care and research in the region.

This funding not only marks a pivotal moment for UTRGV but also signifies a broader commitment to improving cancer research and treatment accessibility in underserved areas. The success of this grant is a testament to the ongoing support from CPRIT and the dedication of UTRGV to make a lasting impact on cancer prevention and research in the Rio Grande Valley.